Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients With Cancer
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00617-15
Full Text
Open PDFAbstract
Available in full text
Date
October 19, 2015
Authors
Publisher
American Society for Microbiology